SHERI WAGES CORNELL: Open Payments
NPI 1760457345 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 26 payments from 20 companies in 2025. Trend: 2023 $266 · 2024 $0 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| GlaxoSmithKline, LLC. | 1 | $64 |
| PFIZER INC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Rigel Pharmaceuticals, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $30 |
| Exelixis Inc. | 1 | $28 |
| Stemline Therapeutics Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $27 |
Products named: JEMPERLI, TAVALISSE, DATROWAY, VERZENIO, Enhertu, CABOMETYX, Orserdu, VENCLEXTA.
Industry payments across AZ — which companies pay providers there.
